liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Human Progenitor Cells for Bone Engineering Applications
New York Stem Cell Foundation, New York, NY, USA.
University of Gothenburg, Sweden .
University of Gothenburg, Sweden .
BIOMATCELL VINN Excellence Centre Biomat and Cell Ther, Gothenburg, Sweden.
Show others and affiliations
2013 (English)In: Current molecular medicine, ISSN 1566-5240, E-ISSN 1875-5666, Vol. 13, no 5, 723-734 p.Article in journal (Refereed) Published
Abstract [en]

In this report, the authors review the human skeleton and the increasing burden of bone deficiencies, the limitations encountered with the current treatments and the opportunities provided by the emerging field of cell-based bone engineering. Special emphasis is placed on different sources of human progenitor cells, as well as their pros and cons in relation to their utilization for the large-scale construction of functional bone-engineered substitutes for clinical applications. It is concluded that, human pluripotent stem cells represent a valuable source for the derivation of progenitor cells, which combine the advantages of both embryonic and adult stem cells, and indeed display high potential for the construction of functional substitutes for bone replacement therapies.

Place, publisher, year, edition, pages
Bentham Science Publishers , 2013. Vol. 13, no 5, 723-734 p.
Keyword [en]
Adult stem cells, bone deficiencies, bone engineering, embryonic-derived progenitors, human embryonic stem cells, human skeleton, mesenchymal stem cells
National Category
Natural Sciences
Identifiers
URN: urn:nbn:se:liu:diva-94595DOI: 10.2174/1566524011313050004ISI: 000319324700004OAI: oai:DiVA.org:liu-94595DiVA: diva2:633676
Note

Funding Agencies|BIOMATCELL VINN Excellence Center of Biomaterials and Cell Therapy, Region Vastra Gotland, Swedish Research Council|K2009-52X-09495-22-32005-7544|

Available from: 2013-06-27 Created: 2013-06-27 Last updated: 2017-12-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Authority records BETA

Hyllner, Johan

Search in DiVA

By author/editor
Hyllner, Johan
By organisation
BiotechnologyThe Institute of Technology
In the same journal
Current molecular medicine
Natural Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 25 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf